Content about Symptoms

December 2, 2011
Axia3 launches Axia3 ProDigestive antacid

Axia3 on Thursday announced the launch of its Axia3 ProDigestive antacid as a new dietary supplement that delivers relief from occasional heartburn, with a proprietary blend of potent ProDigestive enzymes to help promote healthy digestion.

LOS ANGELES — Axia3 on Thursday announced the launch of its Axia3 ProDigestive antacid as a new dietary supplement that delivers relief from occasional heartburn, with a proprietary blend of potent ProDigestive enzymes to help promote healthy digestion.

"Heartburn and other digestive discomforts such as indigestion, sour stomach and bloating afflict millions of people each year," Axia3 CEO Ryan Doheny said. "In fact, more than 100 million people in the U.S. each year suffer from heartburn."

October 19, 2011
Survey: Seniors not aware medicines can cause constipation

Many of this country's 80 million baby boomers who take medications for such conditions as pain, high cholesterol, hypertension and even depression are not aware that some of those medications could lead them to seek relief from occasional constipation.

STAMFORD, Conn. — Many of this country's 80 million baby boomers who take medications for such conditions as pain, high cholesterol, hypertension and even depression are not aware that some of those medications could lead them to seek relief from occasional constipation, according to a nationwide survey of 1,150 men and women age 50 years or older taking medications for common medical conditions released by Purdue Products Wednesday.

October 5, 2011
Zarbee's launches children's cough and sleep drink

Zarbee's on Wednesday announced the launch of Zarbee's Nighttime Cough and Sleep Drink, an over-the-counter nighttime cough remedy.

SALT LAKE CITY — Zarbee's on Wednesday announced the launch of Zarbee's Nighttime Cough and Sleep Drink, an over-the-counter nighttime cough remedy.

Zarbee's Nighttime Cough and Sleep Drink is made from antioxidant-rich buckwheat honey, which recent clinical studies have shown is more effective at relieving coughs associated with colds and upper respiratory illnesses than dextromethorphan or diphenhydramine, the company claimed.

September 12, 2011
Taking it to-go

Portable oral care continues to experience strong growth and, if prior sales periods are any indication of what’s ahead, the segment will likely continue to flourish.

Portable oral care continues to experience strong growth and, if prior sales periods are any indication of what’s ahead, the segment will likely continue to flourish.

Sales of portable oral care for the 52 weeks ended Aug. 7 at food, drug and mass (excluding Walmart) experienced double-digit growth, climbing 43% to $13.2 million, according to SymphonyIRI Group.

September 6, 2011
Back pain intensity increases with weight, study finds

Overweight people with lower back pain is more intense than people of normal weight with back pain, according to a recent study published in the Sept. 15 issue of Spine.

PHILADELPHIA — Overweight people with lower back pain is more intense than people of normal weight with back pain, according to a recent study published in the Sept. 15 issue of Spine.

The study sets up another comorbidity associated with being overweight.

August 30, 2011
Eisai drug shows 'significant' reduction in epileptic seizures

A drug under late-stage clinical development by Eisai reduced the frequency of seizures in patients with epilepsy, according to trial results the drug maker presented Tuesday at the 2011 International Epilepsy Congress.

WOODCLIFF LAKE, N.J. — A drug under late-stage clinical development by Eisai reduced the frequency of seizures in patients with epilepsy, according to trial results the drug maker presented Tuesday at the 2011 International Epilepsy Congress.

August 29, 2011
Hyland's launches new kid-friendly cold product; on shelves in mass in January

Hyland's launched a new Hyland’s Baby cough syrup for infants 6 months and older, the company announced earlier this month.

LOS ANGELES — Hyland's launched a new Hyland’s Baby cough syrup for infants 6 months and older, the company announced earlier this month.

“Finding safe medicines for babies is challenging for parents,” stated Amy Fox, VP product innovation at Hyland’s. “The medicine itself was formulated specifically to cover the wide range of cold-related coughs, from the tickling cough to the dry cough.”

August 19, 2011
Sagent launches neuromuscular disorder drug

Generic drug maker Sagent Pharmaceuticals has launched a new drug for neuromuscular disorders, the company said.

SCHAUMBURG, Ill. — Generic drug maker Sagent Pharmaceuticals has launched a new drug for neuromuscular disorders, the company said.

Sagent announced the launch of vecuronium bromide, an injectable drug used to treat myasthenia gravis and Eaton-Lambert syndrome. The disorders cause muscle weakness and fatigue.

The market for vecuronium bromide is about $10 million in the United States, according to IMS Health.

July 11, 2011
Upsher-Smith Labs launches topical medication for skin itching and inflammation

Upsher-Smith Labs has launched a topical medication for itching and inflammation of the skin resulting from such conditions as psoriasis and atopic dermatitis, the company said Monday.

MAPLE GROVE, Minn. — Upsher-Smith Labs has launched a topical medication for itching and inflammation of the skin resulting from such conditions as psoriasis and atopic dermatitis, the company said Monday.

Upsher-Smith announced the launch of Trianex (triamcinolone acetonide) ointment, which the company described as a prescription topical corticosteroid that offers the feel of a cream and the strength of an ointment.

July 7, 2011
Diabetics cite fatigue as daily challenge

As many as 85% of people with diabetes identified fatigue as one of their leading daily challenges, according to a recent survey of 8,000 diabetics commissioned by Diabetica Research Solutions.

BOCA RATON, Fla. — As many as 85% of people with diabetes identified fatigue as one of their leading daily challenges, according to a recent survey of 8,000 diabetics commissioned by Diabetica Research Solutions.

Only 6% of survey respondents noted, however, that they use energy drinks.

July 7, 2011
Intimina by LELO

LELO has launched a high-end line of Kegel exercisers called Laselle under the Intimina by LELO brand for women with incontinence issues. Such factors as pregnancy, childbirth, aging and obesity can result in the weakening of the pelvic muscles, leading to possible urinary or bowel incontinence.

LELO has launched a high-end line of Kegel exercisers called Laselle under the Intimina by LELO brand for women with incontinence issues. Such factors as pregnancy, childbirth, aging and obesity can result in the weakening of the pelvic muscles, leading to possible urinary or bowel incontinence. A meta-analysis of randomized controlled trials by the Cochrane Collaboration concluded that pelvic exercises should be included in first-line conservative management programs for women with urinary incontinence.

June 26, 2011
BackJoy, the patented back orthotic, bows at Marketplace

BackJoy Orthotics, a newcomer to NACDS Marketplace, is showing retailers its patented orthotic support device, the BackJoy.

BOSTON — BackJoy Orthotics, a newcomer to NACDS Marketplace, is showing retailers its patented orthotic support device, the BackJoy.

Retailing for just $39.95, the BackJoy is a special orthotic cradling system that encourages users to engage their core muscles when seated, rather than slumping down and putting undue pressure and strain on the lower back.

June 20, 2011
Hyland’s to ‘Defend’ adults from colds with new line

Hyland’s will attempt to parlay its success across its 4 Kids line of homeopathic solutions into the adult section with its recent launch of the Hyland’s Defend line.

NEW YORK — Hyland’s will attempt to parlay its success across its 4 Kids line of homeopathic solutions into the adult section with its recent launch of the Hyland’s Defend line. “We are seeing tremendous growth in our cold and cough 4 Kids,” noted Jay Borneman, chairman and CEO at Hyland’s. 


May 31, 2011
Solesta approved by FDA as fecal incontinence treatment

The Food and Drug Administration has approved an injectable gel for fecal incontinence, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved an injectable gel for fecal incontinence, the agency said.

The FDA announced the approval of Oceana Therapeutics’ Solesta for patients who have involuntarily lost bowel control and for whom such therapies as diet change, fiber therapy and antimotility medications have failed.

Fecal incontinence affects more than 5.5 million Americans, according to the National Institutes of Health.

April 25, 2011
AP Pharma announces financing, appoints new executives

Drug maker AP Pharma has appointed two new executives and may receive financing of up to $4.5 million, the company said Monday.

REDWOOD CITY, Calif. — Drug maker AP Pharma has appointed two new executives and may receive financing of up to $4.5 million, the company said Monday.

AP announced the appointment of John Whelan as president, CEO and director, and Michael Adam as SVP and COO.

April 25, 2011
RediClinic introduces Weigh Forward

RediClinic, which operates 29 clinics inside H-E-B grocery stores in Houston, Austin and San Antonio, is launching in May the new Weigh Forward medically supervised weight-loss program.

HOUSTON — RediClinic, which operates 29 clinics inside H-E-B grocery stores in Houston, Austin and San Antonio, is launching in May the new Weigh Forward medically supervised weight-loss program.

Weigh Forward, which was developed in partnership with weight-loss expert David Katz, will be available starting May 16 at all 29 RediClinic locations.

April 25, 2011
‘Defend’-ing against cold and cough

LOS ANGELES — Hyland’s is looking to parlay its success across its 4Kids line of homeopathic solutions into the adult section with the launch of the Hyland’s Defend line. The company already is recognized by parents for cold relief, with Hyland’s Cold & Cough 4Kids product sales growing by 250% per year, according to the company. 


SymphonyIRI Group has Hyland’s liquid cough-cold offerings at $5.6 million in sales across food, drug and mass (excluding Walmart) for the 52 weeks ended March 20 — up 388.4%.


March 23, 2011
Study: GERD sufferers don't discuss symptoms with doctors

Most patients that suffer from gastroesophageal reflux disease or persistent heartburn symptoms rarely speak with a healthcare provider about their condition, according to a new study conducted on behalf of the American Gastroenterological Association, in partnership with drug maker Takeda.

BETHESDA, Md. — Most patients that suffer from gastroesophageal reflux disease or persistent heartburn symptoms rarely speak with a healthcare provider about their condition, according to a new study conducted on behalf of the American Gastroenterological Association, in partnership with drug maker Takeda.

March 9, 2011
Prestige preparing big pediatric cough-cold splash

You can expect to see quite a bit of co-promotional activity between PediaCare and Little Remedies in the 2011-2012 cough-cold season, Prestige Brands president and CEO Matthew Mannelly told investors Wednesday morning at the Bank of America Merrill Lynch 2011 Consumer Conference held here.

NEW YORK — You can expect to see quite a bit of co-promotional activity between PediaCare and Little Remedies in the 2011-2012 cough-cold season, Prestige Brands president and CEO Matthew Mannelly told investors Wednesday morning at the Bank of America Merrill Lynch 2011 Consumer Conference held here.

March 4, 2011
PPIs time out to Tums

NEW YORK — Sure, the plethora of proton-pump inhibitors dotting digestive aisles these days have generated plenty of buzz among antacids, but what do heartburn sufferers do while they wait for the PPI to begin working? They turn to an immediate relief option like the Tums and Tums Ultra brands, which together generated growth of 96.3% to $24.9 million for the 12 weeks ended Jan. 23 across food, drug and mass (minus Walmart), according to SymphonyIRI Group data.

March 4, 2011
Splintek wants consumers to breathe right with SleepRight

KANSAS CITY, Mo. — Splintek Health Products recently launched its SleepRight Nasal Breathe Aid — a snore-relieving product entry into the nasal strip category that retails for a suggested $11.99.

According to the company, the product reduces snoring, relieves nasal congestion and is adhesive-free and reusable. Flexible flares expand the nasal passages to significantly increase airflow, while forming to the shape of the user’s nose for a custom, comfortable fit. Each SleepRight Breathe Aid lasts up to 15 days. 

February 23, 2011
Honey Naturals employs social media on competitive product exchange

Honey Naturals last week started offering parents a free bottle of Zarbee’s children’s cough syrup in exchange for a Facebook photo of them discarding a competitive brand of cough syrup.

SANDY, Utah — Honey Naturals last week started offering parents a free bottle of Zarbee’s children’s cough syrup in exchange for a Facebook photo of them discarding a competitive brand of cough syrup.

February 23, 2011
SleepRight adds nasal breathe aids to lineup

Splintek Health Products recently launched its SleepRight nasal breathe aide — a snore-relieving product entry into the nasal strip category that retails for a suggested price of $11.99.

KANSAS CITY, Mo. — Splintek Health Products recently launched its SleepRight nasal breathe aid — a snore-relieving product entry into the nasal strip category that retails for a suggested price of $11.99.

According to the company, the product reduces snoring, relieves nasal congestion and is adhesive-free and reusable. Flexible flares expand the nasal passages to significantly increase airflow, while forming to the shape of the user’s nose for a custom, comfortable fit. Each breathe aid is reusable and lasts up to 15 days.

February 18, 2011
Second half of cold-flu season may cough up sales

NEW YORK — The second half of the 2010-2011 cough-cold-flu season actually may realize greater sales of symptom relievers than last year, judging from the four weeks ended Dec. 26. According to Matrixx president and CEO Bill Hemelt, sales of remedies were on the rise in those four weeks. Hemelt noted that the total cough-cold category was 5% higher than the same period last year and growing. 


January 28, 2011
Depressive diabetics' spouses also experience distress, study finds

Spouses of older patients with diabetes tend to experience distress if the diabetic patient has symptoms of depression, according to a new study.

WEST LAFAYETTE, Ind. — Spouses of older patients with diabetes tend to experience distress if the diabetic patient has symptoms of depression, according to a new study.